Prevalence and prognostic impact of retropharyngeal lymph nodes metastases in oropharyngeal squamous cell carcinoma: Meta‐analysis of published literature

G Tirelli, N Gardenal, E Zanelli, D Borsetto… - Head & …, 2022 - Wiley Online Library
Background This systematic review and meta‐analysis aims to estimate the prevalence and
prognostic impact of retropharyngeal lymph node metastases (RLNMs) in oropharyngeal …

Comparing outcomes for patients with human papillomavirus (HPV) type 16 versus other high-risk HPV types in oropharyngeal squamous cell carcinoma

RF Shenker, NH May, JD Waltonen, JP Yang… - Head and Neck …, 2021 - Springer
Human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma
(OPSCC) is related to improved treatment outcomes. What remains unclear is whether all …

Timing of radiotherapy and chemotherapy start for patients treated with definitive concurrent chemoradiation for head and neck cancer

CR Steber, GB Russell, MC Rush, RF Shenker… - Acta …, 2022 - Taylor & Francis
Background The ideal timing for the initiation of chemotherapy and radiation therapy (RT) in
the use of definitive chemoradiation (CRT) for patients with head and neck cancer is not well …

Chemoradiotherapy with high‐dose cisplatin compared with weekly cisplatin for locally advanced head and neck squamous cell carcinoma

RT Hughes, M Porosnicu, BJ Levine… - Journal of medical …, 2021 - Wiley Online Library
Introduction Concurrent chemoradiotherapy (CRT) using high‐dose cisplatin (HDC) is
standard for patients with locally advanced head and neck squamous cell carcinoma …

Radiotherapy for oropharyngeal carcinoma with an uninvolved contralateral neck: the safety of omission of contralateral high level II and retropharyngeal lymph nodes …

Z Iyizoba-Ebozue, LJ Murray, S Ramasamy, M Sen… - Clinical Oncology, 2021 - Elsevier
Aims To analyse outcomes and patterns of failure in patients with oropharyngeal carcinoma
(OPC) treated with definitive volumetric modulated arc therapy with omission of contralateral …

[HTML][HTML] Retropharyngeal lymph node-sparing radiotherapy in patients with oropharyngeal carcinoma

BH Kang, KY Eom, C Song, JH Kim… - Radiation Oncology …, 2021 - ncbi.nlm.nih.gov
Purpose In radiotherapy for head and neck cancer, it is crucial to define the appropriate
treatment volume to determine treatment outcome and toxicity. We examined the feasibility …

[HTML][HTML] Radioterapia del grupo ganglionar retrofaríngeo y retroestiloídeo:¿ Cuándo ya quién? Una revisión de la literatura

M Alberdi, M Torres, F Lorenzo - … y cirugía de cabeza y cuello, 2024 - SciELO Chile
La radioterapia de cabeza y cuello posee un rol central en el tratamiento de las neoplasias
otorrinolaringológicas, ya sea como tratamiento adyuvante a la cirugía o como terapia …

[PDF][PDF] Prevalence and prognostic impact of retropharyngeal lymph nodes metastases in oropharyngeal squamous cell carcinoma: Meta-analysis of published …

V Phillips - 2022 - researchgate.net
Background: This systematic review and meta-analysis aims to estimate the prevalence and
prognostic impact of retropharyngeal lymph node metastases (RLNMs) in oropharyngeal …

In reply to McDowell et al.

D Maskell, H Buckley, K Sisson, T Roques… - Head & …, 2019 - search.ebscohost.com
To the Editor, We thank McDowell and colleagues for their valuable comments and
interpretation of our data. We absolutely agree that minimizing treatment volumes is key to …